Search clinical trials for: insulin Glargine Insulin Apidra
Total 2806 results
-
Emory UniversitySanofi; University of MiamiCompletedHyperglycemia | DiabetesUnited States
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentUnknownInsulin-requiring Type 2 Diabetes MellitusGermany
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
SanofiTerminatedAMICanada, Brazil, United States, Argentina, Mexico
-
Rabin Medical CenterSanofiTerminated
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Brazil, Israel, Lebanon, Mexico, Morocco, Peru, Saudi Arabia, United Arab Emirates, Venezuela
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
IKFE Institute for Clinical Research and DevelopmentCompleted
-
Emory UniversitySanofiCompletedDiabetic KetoacidosisUnited States
-
Emory UniversitySanofiCompletedType 2 Diabetes | Inpatient HyperglycemiaUnited States
-
SanofiCompletedDiabetes Mellitus, Type 1Tunisia, South Africa, Algeria, Argentina, Brazil, Colombia, Kuwait, Mexico, Saudi Arabia
-
SanofiCompleted
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Completed
-
Emory UniversityCompletedPoor Glycemic ControlUnited States
-
SanofiCompletedDiabetes Mellitus, Insulin-DependentUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
SanofiTerminated
-
Guillermo Umpierrez, MDMedical University of South Carolina; Sanofi; Texas A&M UniversityCompletedHyperglycemia | Type 2 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Cairo UniversityCompletedDiabetes Mellitus (DM)Egypt
-
Population Health Research InstituteCompletedHyperglycemia | Myocardial Infarction | Cardiovascular DiseasesArgentina, Canada, India
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type IIUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Serbia, Bulgaria, Australia, Korea, Republic of, Thailand, Turkey, United Arab Emirates, Hungary
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Sweden, Malaysia, France, Netherlands, India, Argentina, South Africa, Romania, Former Serbia and Montenegro, Austria, Czech Republic, Philippines, Mexico
-
Cairo UniversitySanofiUnknownLiver Cirrhosis | Type 2 DiabetesEgypt
-
SanofiCompletedType 2 Diabetes MellitusChina
-
SanofiTerminatedDiabetes Mellitus, Type 2Netherlands
-
Guillermo UmpierrezCompleted
-
SanofiTerminatedType 1 Diabetes MellitusUnited States, Canada
-
Loyola UniversitySanofiCompletedRenal Insufficiency | Type 2 DiabetesUnited States
-
Fundación Pública Andaluza para la Investigación...CompletedType 1 Diabetes MellitusSpain
-
Novo Nordisk A/SCompleted
-
IRCCS San RaffaeleTerminatedType 2 Diabetes Mellitus | Peripheral Vascular DiseaseItaly
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Germany, Turkey, Greece
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
Emory UniversityCompletedBenefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
SanofiCompleted
-
University of AarhusCompletedDiabetes Mellitus, Type 1Denmark
-
Novo Nordisk A/SRecruitingObesity | Diabetes Mellitus, Type 2United States, Spain, Portugal, Italy, Greece, Romania, Slovakia, Czechia, South Africa, Ukraine
-
Universidad de GuanajuatoCompleted